Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
| Brand name | DEXTROSE |
| Generic name | DEXTROSE |
| Active ingredient(s) | DEXTROSE |
| Distributed by / for | B BRAUN MEDICAL INC |
| NDC | 0264-7387-50 |
| Full product label | DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50. |
| Recalling firm | B BRAUN MEDICAL INC |
| Distribution | US Nationwide. |
| Quantity | 17,124 bags |
| Recall initiated | 2026-04-02 |
| Report date | 2026-04-29 |
| Recall completed | — |
| Recall number | D-0496-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Allentown PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗